Becton Dickinson & Company
Becton Dickinson and Co, formerly Becton Dickinson & Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company' s operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. On February 9, 2012, the Company acquired a 100% interest in KIESTRA Lab Automation BV. On August 24, 2012, the Company acquired a 100% interest in Sirigen Group Limited. On October 31, 2012, the Company sold its BD Biosciences -Discovery Labware unit. In December 2012, the Company acquired Safety Syringes, Inc. Effective March 12, 2013, the Company acquired Cato Software Solutions GmbH.
Profit margin stands at 8.0%.
Current Price
$154.51
-1.17%GoodMoat Value
$146.37
5.3% overvaluedBecton Dickinson & Company (BDX) Stock Chart
BDX Interactive Stock Chart
Interactive stock chart for Becton Dickinson & Company (BDX) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.
Current price: $154.51. 52-week high: $184.21. 52-week low: $126.84. 50-day moving average: $165.18. 200-day moving average: $150.94.
Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for BDX. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of Becton Dickinson & Company's investment potential.